Rapid analysis of the Vβ repertoire of CD4 and CD8 T lymphocytes in whole blood

Journal of Immunological Methods

Volumn 283, Issue 1-2, 2003, Pages 9-15

  MacIsaac, Christopher ^a,b   Curtis, Nigel ^b,c,d   Cade, John ^a   Visvanathan, Kumar ^b,c,d  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Flow cytometry; Genes; Lymphocytes; Superantigens; T cell receptor; T cell receptor beta; Toxic shock

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CELL POPULATION; DIAGNOSTIC TEST; EVALUATION; FEMALE; HUMAN; IMMUNOLOGICAL TECHNIQUE; PRIORITY JOURNAL; SCHOOL CHILD; STAPHYLOCOCCUS; STREPTOCOCCUS; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

EID: 0345059090     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00260-6     Document Type: Article

References (26)

1. Bannan J., Visvanathan K., Zabriskie J.B. Structure and function of streptococcal and staphylococcal superantigens in septic shock. Infect. Dis. Clin. North Am. 13:1999;387-396. (ix).
2. Beckman C., 2000. IOTest® Beta Mark PN IM3497. Product Information: Quick Reference Card.
3. Bunikowski R., Mielke M.E., Skarabis H., Worm M., Anagnostopoulos I., Kolde G., Wahn U., Renz H. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J. Allergy Clin. Immunol. 105:2000;814-819.
4. Choi Y., Lafferty J.A., Clements J.R., Todd J.K., Gelfand E.W., Kappler J., Marrack P., Kotzin B.L. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172:1990;981-984.
5. Davis M.M., Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition. Nature. 334:1988;395-402.
6. Davison S.C., Allen M.H., Mallon E., Barker J.N. Contrasting patterns of streptococcal superantigen-induced T-cell proliferation in guttate vs. chronic plaque psoriasis. Br. J. Dermatol. 145:2001;245-251.
7. Diu A., Fevrier M., Mollier P., Charron D., Banchereau J., Reinherz E.L., Theze J. Further evidence for a human B cell activating factor distinct from IL-4. Cell. Immunol. 125:1990;14-28.
8. Gorski J., Yassai M., Zhu X., Kissela B., Kissella B., Keever C., Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J. Immunol. 152:1994;5109-5119.
9. Hemmer B., Gran B., Zhao Y., Marques A., Pascal J., Tzou A., Kondo T., Cortese I., Bielekova B., Straus S.E., McFarland H.F., Houghten R., Simon R., Pinilla C., Martin R. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat. Med. 5:1999;1375-1382.
10. Herman A., Labrecque N., Thibodeau J., Marrack P., Kappler J.W., Sekaly R.P. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc. Natl. Acad. Sci. U. S. A. 88:1991;9954-9958.
11. Kou Z.C., Halloran M., Lee-Parritz D., Shen L., Simon M., Sehgal P.K., Shen Y., Chen Z.W. In vivo effects of a bacterial superantigen on macaque TCR repertoires. J. Immunol. 160:1998;5170-5180.
12. Li Y., Sun G.R., Zheng Q., Yoo D.H., Bhardwaj N., Posnett D.N., Crow M.K., Friedman S.M. Allelic variants of human TCR BV17S1 defined by restriction fragment length polymorphism, single strand conformation polymorphism, and amplification refractory mutation system analyses. Hum. Immunol. 49:1996;85-95.
13. Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 17:1999;435-466.
14. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:2001;77-104.
15. Meissner H.C., Leung D.Y. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr. Infect. Dis. J. 19:2000;91-94.
16. Ohmen J.D., Barnes P.F., Grisso C.L., Bloom B.R., Modlin R.L. Evidence for a superantigen in human tuberculosis. Immunity. 1:1994;35-43.
17. Oksenberg J.R. Immunogenetics and heterogeneity in multiple sclerosis. Ann. Neurol. 40:1996;557-558.
18. Pannetier C., Cochet M., Darche S., Casrouge A., Zoller M., Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. U. S. A. 90:1993;4319-4323.
19. Roth M.E., Lacy M.J., McNeil L.K., Kranz D.M. Analysis of T cell receptor transcripts using the polymerase chain reaction. BioTechniques. 7:1989;746-754.
20. Roth M.E., Tjoa B.A., Schlueter C.J., Wilson E.R., Lunn B.C., Kranz D.M. Sequence diversity of T cell receptor alpha chain transcripts from BALB/c thymus. Mol. Immunol. 29:1992;1447-1455.
21. Rowen L., Koop B.F., Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science. 272:1996;1755-1762.
22. Smoot L.M., McCormick J.K., Smoot J.C., Hoe N.P., Strickland I., Cole R.L., Barbian K.D., Earhart C.A., Ohlendorf D.H., Veasy L.G., Hill H.R., Leung D.Y., Schlievert P.M., Musser J.M. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect. Immun. 70:2002;7095-7104.
23. Straten P.T., Guldberg P., Seremet T., Reisfeld R.A., Zeuthen J., Becker J.C. Activation of preexisting T cell clones by targeted interleukin 2 therapy. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8785-8790.
24. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 269:1993;390-391.
25. Todd J.K. Toxic shock syndrome: a perspective through the looking glass. Ann. Intern. Med. 96:1982;839-842.
26. Wack A., Montagna D., Dellabona P., Casorati G. An improved PCR-heteroduplex method permits high-sensitivity detection of clonal expansions in complex T cell populations. J. Immunol. Methods. 196:1996;181-192.